Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer

Clinical trial NCT03970252 · COMPLETED

Trial details

NCT number: NCT03970252
Sponsor: Jonsson Comprehensive Cancer Center
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Borderline Resectable Pancreatic Adenocarcinoma Resectable Pancreatic Ductal Adenocarcinoma

Start date: 2019-07-24
Primary completion: 2024-05-25
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.